NCT06379958View on ClinicalTrials.gov

Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Pharmacokinetics
Interventions
DRUG

leramistat 40mg

Oral capsule

DRUG

Itraconazole 200 mg

Oral capsule

DRUG

Phenytoin 100 Mg Oral Capsule

Oral capsule

DRUG

Simvastatin 40mg

Oral capsule

DRUG

Upadacitinib 15 MG

Oral Capsule

Trial Locations (1)

Unknown

RECRUITING

Celerion, Belfast

Sponsors
All Listed Sponsors
lead

Modern Biosciences Ltd

INDUSTRY

NCT06379958 - Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter